MEI Pharma, Inc. Financial Ratios — MEIP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-101.94	-142.74	-52.12	-62.88	-57.08	-37.28	5.19	-49.97	-17.96	-32.27	-21.53	-30.95	-21.32	21.92	-53.45
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-1.52	- -	- -	- -	- -	- -	- -	-4.55	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	5.15	- -	- -	- -	- -	- -	- -	72.3	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	78.49	-108.57	13.27	90.38	95.95	100	100	100	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	10.62	-1,759.12	-939.27	-92.19	-172.83	-184.68	-74.52	39.55	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	10.25	-1,762.39	-940.9	-92.58	-173.65	-185.48	-75.31	38.96	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	100.6	- -	- -	- -	- -	- -	- -	377.43	65.69
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	11.49	-2,470.22	-342.18	-169.95	-118.71	-133.8	-65.22	27.23	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	11.48	-2,470.28	-342.2	-169.96	-118.73	-133.8	-65.22	27.23	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	11.48	-2,470.28	-342.2	-169.96	-118.73	-133.8	-65.22	27.23	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	0.04	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	65.59	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	10	13	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	9	11	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.14	-0.13	-0.35	- -	- -
Net Debt/EBITDA	0.6	0.74	3.18	0.51	0.57	0.52	-3.43	0.47	0.21	0.48	0.14	0.21	0.46	-0.14	1.05
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.14	-0.13	-0.35	- -	- -
Net Debt/EBIT	0.6	0.74	3.17	0.51	0.57	0.52	-3.55	0.47	0.21	0.48	0.14	0.21	0.46	-0.15	1.03
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-1,861.52	-1,335.49	-263.49	-247.84	-241.14	-375.29	-312.96	-204.86	-279.71	-132.74	-183.64	-210.39	-336.07	-938.29	-2,210.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.9	16.73	45.89	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.37	-2.41	-2.87	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.23	4.93	9.35	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.78	18.4	51.69	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.66	-2.65	-3.24	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.77	5.42	10.54	- -	- -
Net Debt to Equity	-215.05	-134.86	-102.01	-30.49	-31.31	-26.02	-16.64	-26.38	-20.01	-16	-17.27	-30.03	-68.66	-11.22	-106.38
Net Debt/Capital (%)	4.74	6.79	26.98	10.04	10.71	5.77	4.63	5.84	3.98	4.24	2.67	4.14	4.12	0.95	4.27
EBITDA	-6	-8	-11	-27	-33	-21	2	-29	-46	-26	-60	-75	-36	26	-17
EBITDA-CapEx	-6	-8	-11	-27	-33	-21	2	-29	-46	-26	-61	-76	-36	26	-17
Operating Income (Loss)	-6	-8	-11	-27	-33	-21	2	-29	-46	-26	-60	-75	-37	25	-17

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.63	3.5	21.24	10.57	12.86	8.33	11.01	13.03	5.21	13.28	7.59	6.27	4.95	4.59	13.3
Current Ratio	1.74	3.58	21.51	10.68	12.96	8.48	11.37	13.23	5.75	15.17	8.15	6.84	5.29	4.88	13.5
Quick Ratio	1.63	3.5	21.24	10.57	12.86	8.33	11.01	13.03	5.58	14.97	7.97	6.68	4.95	4.59	13.3
CFO/Avg Current Liab	-3.15	-3.41	-5.82	-6.18	-5.86	-3.41	0.67	-3.3	-2.65	2.44	-1.88	-2.18	-2.34	-3.52	-4.29
Common Equity/Total Assets	-1,861.52	-1,335.49	-263.49	-247.84	-241.14	-375.29	-312.96	-204.86	-279.71	-132.74	-183.64	-210.39	-336.07	-938.29	-2,210.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.9	16.73	45.89	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.37	-2.41	-2.87	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.23	4.93	9.35	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.78	18.4	51.69	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.66	-2.65	-3.24	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.77	5.42	10.54	- -	- -
CFO/Total Liabilities	-273.84	-399.15	-599.64	-421.38	-566.02	-323.97	71.64	-38.81	-84.71	25.82	-25.65	-38.86	-54.57	-604.11	-1,539.44
CFO/CapEx	-135.44	- -	-264.32	-389.02	-1,871.27	-4,464.25	68.35	- -	-135.59	38.32	-45.15	-101.77	-1,499.54	-7,210.43	- -
Altman's Z-Score	-29.13	-20.69	16.54	8.61	0.56	-1.76	5.67	-1.25	-2.35	0.31	-1.32	-2.87	-4.23	-7.2	-32.98

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	6.01	1.6	1.01	0.74	0.32	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	60.74	228.08	360.89	493.59	1,139.59	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-60.74	-228.08	-360.89	-493.59	-1,139.59	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	6	4	56	99	37	36	68	127	138	292	249	59	34	19	- -
- Cash & Cash Equivalents	4	6	36	14	19	11	8	13	10	12	9	16	17	4	18
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	10	13	- -	- -
Enterprise Value	2	-2	21	50	-26	-10	15	24	64	110	104	-85	-54	-19	-18
Total Capital	-78	-85	-96	-123	-156	-177	-174	-214	-231	-278	-311	-365	-393	-388	-404
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.66	-2.65	-3.24	- -	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.08	-0.11	-0.24	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	0.64	14.83	12.95	3.95	2.99	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	5.99	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	6.2	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	4.24	- -	- -	3.2	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	4.18	- -	- -	3.12	- -	- -	- -	- -	- -
Diluted Market Cap	6	4	56	99	37	36	69	127	141	292	253	59	34	19	- -
Diluted Enterprise Value	2	-2	21	85	19	26	60	113	131	280	253	53	30	16	-18
EV per Share	34.51	- -	40.75	49.86	- -	- -	8.03	11.61	17.9	24.06	18.49	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	23	2	5	28	35	41	49	65	- -
TTM EBITDA	-6	-8	-11	-27	-33	-21	2	-29	-46	-26	-60	-75	-36	26	-17
TTM Operating Income	-6	-8	-11	-27	-33	-21	2	-29	-46	-26	-60	-75	-37	25	-17
TTM Cash Flow to Firm	-7	-7	-10	-19	-28	-18	3	-21	-29	34	-32	-49	-52	-50	-21
TTM Free Cash Flow to Firm	-6	-7	-10	-19	-28	-18	4	-21	-29	35	-31	-48	-52	-50	-21

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-0.94	-0.62	-5.62	-5.09	-1.34	-2.04	19.39	-6.03	-4.81	8.31	-8.11	-1.23	-0.65	-0.38	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	6.2	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	-2	21	50	-26	-10	15	24	64	110	104	-85	-54	-19	-18
Low Price	85.2	49.2	39.6	110.2	33	17.4	26.4	35.8	36.4	14.4	45.8	8.2	4	2.73	1.46
EV/Sales	- -	- -	- -	- -	- -	- -	0.64	14.83	12.95	3.95	2.99	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	5.99	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	25.6	- -	- -	- -	- -	- -	- -	1.09	- -
Price/Earnings Average	-1.16	-1.47	-4.31	-4.69	-3.33	-1.95	17.86	-2.09	-10.67	-3.26	-6.66	-3.59	-1.17	1.74	- -
Price/Earnings High	-3.92	-5.88	-11.99	-10.33	-7.19	-3.5	34.47	-5.31	-20.3	-8.61	-12.47	-8.12	-2.68	2.95	- -
Price/Earnings Low	-0.8	-0.73	-1.8	-4.07	-1.42	-1.43	18.2	-1.85	-7.7	-1.39	-6.24	-0.94	-0.84	1.02	- -
Price/Book Value	-0.08	-0.05	-0.58	-0.8	-0.24	-0.21	-0.39	-0.59	-0.6	-1.05	-0.78	-0.16	-0.08	-0.05	- -
Price/Book Value Average	-0.1	-0.13	-0.5	-1.03	-0.7	-0.23	-0.27	-0.39	-0.78	-0.55	-0.86	-0.52	-0.09	-0.08	- -
Price/Book Value High	-0.34	-0.52	-1.39	-2.27	-1.5	-0.41	-0.53	-0.99	-1.48	-1.46	-1.61	-1.18	-0.21	-0.14	- -
Price/Book Value Low	-0.07	-0.06	-0.21	-0.9	-0.3	-0.17	-0.28	-0.35	-0.56	-0.24	-0.81	-0.14	-0.07	-0.05	- -
Price/Tangible Book Value	3.38	0.96	1.64	2.21	0.63	0.88	1.35	2.53	2.9	3.79	5.04	1.13	1.38	0.59	- -
Price/Tangible Book Value Average	4.4	2.41	1.4	2.84	1.83	0.99	0.94	1.67	3.76	2	5.56	3.73	1.52	0.94	- -
Price/Tangible Book Value High	14.83	9.62	3.9	6.27	3.96	1.77	1.82	4.25	7.16	5.27	10.42	8.43	3.46	1.59	- -
Price/Tangible Book Value Low	3.02	1.2	0.58	2.47	0.78	0.72	0.96	1.48	2.72	0.85	5.21	0.97	1.08	0.55	- -
Price/Sales	- -	- -	- -	- -	- -	- -	2.94	78.17	28.11	10.53	7.16	1.45	0.7	0.3	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	2.05	51.53	36.5	5.55	7.9	4.81	0.77	0.47	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	3.96	131.29	69.47	14.64	14.81	10.86	1.75	0.8	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	2.09	45.72	26.34	2.36	7.41	1.25	0.55	0.28	- -
Price/Cash Flow	-0.93	-0.62	-5.6	-5.08	-1.33	-2.04	19.61	-6.03	-4.7	8.53	-7.79	-1.21	-0.65	-0.38	- -
Price/Cash Flow Average	-1.21	-1.56	-4.8	-6.55	-3.88	-2.28	13.68	-3.97	-6.1	4.49	-8.6	-4.02	-0.71	-0.61	- -
Price/Cash Flow High	-4.09	-6.25	-13.35	-14.42	-8.37	-4.08	26.4	-10.12	-11.61	11.86	-16.12	-9.07	-1.62	-1.04	- -
Price/Cash Flow Low	-0.83	-0.78	-2	-5.68	-1.66	-1.68	13.94	-3.53	-4.4	1.91	-8.06	-1.05	-0.51	-0.36	- -
Price/Free Cash Flow Average	-1.22	-1.56	-4.81	-6.56	-3.88	-2.28	13.53	-3.97	-6.25	4.38	-8.95	-4.08	-0.71	-0.61	- -
Price/Free Cash Flow High	-4.12	-6.25	-13.4	-14.46	-8.37	-4.08	26.11	-10.12	-11.9	11.56	-16.78	-9.2	-1.63	-1.04	- -
Price/Free Cash Flow Low	-0.84	-0.78	-2.01	-5.7	-1.66	-1.68	13.79	-3.53	-4.51	1.87	-8.39	-1.06	-0.51	-0.36	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	1.69	43.32	34.55	5.1	7.9	4.66	0.68	0.42	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	3.59	123.09	67.52	14.19	14.8	10.71	1.66	0.75	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	1.73	37.52	24.39	1.92	7.4	1.1	0.46	0.22	- -
EV/EBITDA Average	-0.63	-0.58	-1.13	-4.18	-2.75	-1.43	15.88	-2.46	-3.68	-5.53	-4.57	-2.52	-0.91	1.06	1.05
EV/EBITDA High	-3.53	-4.54	-8.82	-9.81	-6.61	-2.96	33.85	-7	-7.19	-15.39	-8.57	-5.8	-2.23	1.89	1.05
EV/EBITDA Low	-0.24	0.08	1.38	-3.56	-0.85	-0.91	16.26	-2.13	-2.6	-2.08	-4.28	-0.6	-0.62	0.56	1.05
EV/EBIT Average	-0.62	-0.58	-1.12	-4.17	-2.75	-1.42	16.45	-2.46	-3.67	-5.51	-4.55	-2.51	-0.9	1.07	1.03
EV/EBIT High	-3.53	-4.53	-8.78	-9.79	-6.6	-2.96	35.06	-6.98	-7.18	-15.33	-8.53	-5.77	-2.21	1.92	1.03
EV/EBIT Low	-0.24	0.08	1.38	-3.55	-0.85	-0.91	16.84	-2.13	-2.59	-2.07	-4.26	-0.6	-0.61	0.57	1.03
Last Price	95.08	39.15	110.77	98.5	26.57	21.13	37.13	61.21	38.84	64.16	44.28	9.48	5.11	2.91	2.47
High Price	417.6	393.6	264	279.6	166.6	42.4	50	102.8	96	89.2	91.6	71	12.8	7.87	4.1
Enterprise Value Average	4	5	13	114	90	30	39	70	170	142	275	190	33	27	-18
Enterprise Value High	23	38	99	267	216	62	84	200	332	394	515	436	81	49	-18
Enterprise Value Low	2	-1	-15	97	28	19	40	61	120	53	257	45	22	14	-18

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	1	1	2	2	2	4	4	6	6	7	7	7	7
Diluted Weighted Avg Shares	- -	- -	1	1	1	2	2	2	4	5	6	6	7	7	- -
Basic Weighted Avg Shares	- -	- -	1	1	1	2	2	2	4	5	6	6	7	7	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	12.63	0.78	1.38	6.09	6.18	6.54	7.33	9.8	- -
EBITDA per Share	-101.08	-74.57	-22	-27.09	-23.19	-12.18	1.34	-13.77	-12.98	-5.62	-10.69	-12.08	-5.46	3.88	- -
Operating Income per Share	-101.28	-74.69	-22.09	-27.14	-23.24	-12.21	1.3	-13.8	-13	-5.64	-10.74	-12.13	-5.52	3.82	- -
Basic EPS, GAAP	-106.46	-66.94	-22.02	-27.06	-23.18	-12.13	1.45	-19.34	-4.73	-10.36	-7.34	-8.75	-4.78	2.67	- -
Basic EPS from Cont Ops	-106.46	-66.94	-22.02	-27.06	-23.18	-12.13	1.45	-19.34	-4.73	-10.36	-7.34	-8.75	-4.78	2.67	- -
Diluted EPS, GAAP	-106.46	-66.94	-22.02	-27.06	-23.18	-12.13	1.45	-19.34	-4.65	-10.36	-7.22	-8.7	-4.78	2.67	- -
Diluted EPS from Cont Ops	-106.46	-66.94	-22.02	-27.06	-23.18	-12.13	1.45	-19.34	-4.65	-10.36	-7.22	-8.7	-4.78	2.67	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.75	- -
Cash Flow per Share	-102.06	-63.01	-19.77	-19.39	-19.9	-10.38	1.89	-10.15	-8.27	7.52	-5.68	-7.83	-7.88	-7.58	- -
Free Cash Flow per Basic Share	-102.82	-63.01	-19.84	-19.44	-19.91	-10.38	1.87	-10.15	-8.33	7.33	-5.81	-7.91	-7.88	-7.58	- -
Cash & Equivalents per Share	60.57	55.19	70.02	48.64	45.23	26.7	29.1	49.6	20.94	40.1	27.27	24.62	15.11	5.75	- -
Book Value per Share	-1,218.12	-757.32	-189.55	-123.07	-110.72	-102.91	-94.71	-103.5	-65	-61.13	-56.82	-60.12	-60.93	-58.26	- -
Tangible Book Value per Share	28.17	40.92	67.72	44.62	42.11	24	27.44	24.22	13.4	16.92	8.79	8.42	3.7	4.96	- -

MEI Pharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)